ArticleFrontiers in oncology2022

Atractylenolide I inhibits EMT and enhances the antitumor effect of cabozantinib in prostate cancer

Pengfei Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.